An underground economy for unapproved slimming medications is being driven by social media fitness personalities and vendors on communication apps, based on new investigations.
Experimental Treatment Acquiring Traction Online
Retatrutide, which is still in clinical trials, is being promoted by online personalities for its alleged weight-reducing effects. Viewers are urged to contact these accounts privately for source information, while also obtaining promotional offers.
Active Trade on Social Networks
Additionally, a flourishing market exists on messaging services, where groups with thousands of participants share comparison images, injection guides and assertions of next-day British shipping. Sellers promote the substance there before redirecting buyers to other platforms for transactions.
Learning About Retatrutide
This medication is an experimental injection developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and glucagon. Early trials indicate it could assist patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the substance is being hailed digitally as the successor to Ozempic.
Medical Professionals Express Worries
However, doctors and pharmacists have cautions that the distribution of what remains an unlicensed drug in the United Kingdom is worrisome and could lead to users injecting substances of unknown origin.
Some experts stated the demand for the experimental drug could be linked to the rising price of approved slimming products such as Mounjaro.
Legal Position and Enforcement
Selling retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that must not be marketed or supplied for human use under the Human Medicines Regulations 2012.
Several content creators try to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and supply can still violate medicines, marketing, and customer laws, risking fines, prosecution or imprisonment.
Platform Response and Content Removal
According to the social media company, the platform has taken down problematic content and prohibited related hashtags and query recommendations. The company said it was dedicated to keeping the platform secure and allocating resources in enhancing compliance measures.
Online Trading Activities
Research also discovered groups with up to nine thousand participants marketing retatrutide using the platform's integrated search feature, which functions like a public directory. Typing “retatrutide” immediately displays groups with thousands of users, populated with images of slimming results, glowing testimonials and step-by-step guides for mixing or injecting at home.
Within minutes of joining one community, a vendor shared contact information, where most purchases take place. The seller provided an guidebook and promised shipping within two days. When asked whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. None inquired about weight, health issues or past usage.
Item Details and Pricing
Within these communities, posts show dark colored packages with Royal Mail stickers, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at home with purified liquid, or pre-filled injectors usually priced at 160 pounds for 20 milligrams. When asked how long a injector should last, sellers give contradictory answers varying between a several days to “depends on your body”.
Service Oversight and Security Actions
A spokesperson for the messaging service said it actively monitored harmful material on its service including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Expert Warnings
“People are administering substances they cannot confirm. Although the research behind this drug is sound, these digital versions may not contain what they claim,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the surge in interest to current price rises for approved weight-loss medications such as Mounjaro. “With prices increasing, patients are using social media. But counterfeit treatments are highly risky. You can’t be certain what’s inside or whether the conditions they were produced in was clean,” she said.
Her team has already encountered individuals harmed by self-injection from unverified suppliers. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is gambling with your health,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”
Producer Statement
A representative from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any government authority globally. “Therefore at this time no one can market [it] for personal consumption,” they said, noting that any item “falsely representing itself as a Lilly investigational product not yet approved … may subject patients to potentially serious health risks”.
